RE:RE:RE:RE:RE:RE:RE:RE:RE:New PR The abstracts were submitted awhile back. The R&D behind these posters has probably been ongoing for a year or more. You think if the half dozen to a dozen patients who've had high doses of th1902 haven't shown a response that they would pull these posters from the conference? Of course not! None of this has anything to do with how the Ph1 trial is progressing. Like every other biotech they will be positive about an active program and support it right up to the day it gets dropped (if there is such a day).
jfm1330 wrote: It would be strange to have this PR out with positive comments by Marsolais and absolutely no sign of efficacy in phase Ia while it is close to be completed. I know they would be able to hide behind the excuse that phase Ia is not designed to show efficacy, but it would be surprising given that they are still pushing preclinical data pointing at efficacy against very advanced and resistant cancers involving cancer stem cells.
longterm56 wrote: Biobob wrote: Great news for Minimouse...
Man .. this crowd is getting ugly!! Hang on, all, we haven't yet heard from those
who really know!!!!
-LT